Feature | May 14, 2006 | Cristen Bolan

Imaging Stands Up to DRA

Cristen C. Bolan, Editor

Forty-five percent of the rise in Medicare spending between 1999-2003 was attributed to medical imaging. Although the Stark Law prohibits physician self-referrals, some lawmakers charge physicians with unnecessarily referring patients for imaging exams in order to refer them to outpatient centers where the physician is financially vested, thus incrementing the rise in Medicare costs.
There is no doubt that Medicare coverage for imaging has risen, and perhaps PET (both PET and PET/CT) is the one to blame. It has been in high demand over the last six years due to several factors: it is a noninvasive alternative to surgery, a growing need from an aging population, consumer awareness of the benefits of diagnostic screening, and broadened use for PET applications in oncology for early diagnosis, staging and monitoring recurrence. In 2005, the projected growth for PET was estimated to reach 22.6 percent, according to the 2005 Wash G2 Report. Surprisingly, PET only represented one percent of the 2005 diagnostic imaging market share, said the same report. Studies also point to cost savings due to PET scans where “[t]he average cost of treatment based on a work-up that included a PET scan, as compared to a conventional diagnostic work-up resulted in a savings of 13 percent.”1
Public policy, however, often focuses on cost without considering the clinical and economic value technological innovation delivers. A recent example of this is the Deficit Reduction Act of 2005 (DRA) that Congress just passed. A few highlights of DRA include decreased reimbursements for Medicare in-office imaging services by 50 percent in 2006 and by 75 percent in 2007. Estimates indicate that the measure could cut PET procedures by as much as 50 percent, despite studies that point to the technology’s unprecedented benefits. Then why is Congress short-circuiting technology that effectively improves healthcare?
Many of us can only speculate. Others are taking action. The National Oncologic PET Registry (NOPR) has launched a Web site, www.cancerpetregistry.org, “in response to the Centers for Medicare and Medicaid Services (CMS) proposal to expand coverage for FDG-PET to include cancers and indications not presently eligible for Medicare reimbursement,” reported the Society of Nuclear Medicine (SNM). The 2006 Oncology Demonstration Project will provide Medicare reimbursement for a list of cancers if the patient’s referring physician and the provider submit data to a clinical registry, like NOPR, to assess the impact of PET on cancer patient management.
The diagnostic categories that are currently not eligible for Medicare reimbursement, unless registered through with Demonstration Project, are not uncommon forms of cancer and include: head and neck cancer; esophageal cancer; gastric cancer; colon cancer; rectal; pancreatic cancer; lung cancer; female breast cancer (invasive); ovarian cancer; prostate cancer; non-Hodgkin’s lymphoma; multiple myeloma; and chronic myelogenous leukemia.
Other groups making a statement about the importance of imaging in the fight against cancer and disease prevention are U.S. Oncology and the National Electrical Manufacturers Association (NEMA). The two groups recently hosted a Capitol Hill forum, moderated by Congressman Mike Rogers (R-MI), chair of the House of Representatives Cancer Care Working Group. The event underscored growing national awareness that medical imaging combined with pharmaceutical therapies can diagnose and treat cancer earlier.
“A comprehensive approach to cancer diagnosis and treatment has a tremendous impact on patients across the entire nation,” said Congressman Rogers. “With emerging research continually pointing to imaging as a crucial part of that care continuum, ensuring that all Americans can access quality imaging services is absolutely essential.”
The idea is that imaging enables early detection, which allows patients to avoid costly surgeries and procedures, and to live longer. Isn’t cutting healthcare costs a primary objective of the DRA bill? Maybe the numbers got in the way of taking a “comprehensive approach” to better care.
1. Verboom, P et al. “Cost-Effectiveness of FDG-PET in Staging Non-Small Cell Lung Cancer: The PLUS Study.” The European Journal of Nuclear Medicine and Molecular Imaging. 30.11 (2003).

Related Content

Osprey Medical and GE Healthcare Launch Acute Kidney Injury Educational Program
News | Angiography | September 25, 2018
September 21, 2018 — Osprey Medical announced a collaboration with GE Healthcare on Osprey’s Be Kind to Kidneys campa
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cardiac Imaging | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...

Image courtesy of Siemens Healthineers

Feature | CT Angiography (CTA) | September 06, 2018 | Dave Fornell
There have been a few big, recent advancements in cardiac computed tomography angiography (CCTA) imaging technology....
HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | Angiography | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...
360 View of a Cath Lab at Northwestern Medicine Central DuPage Hospital
360 Photos | Angiography | May 03, 2018
A 360 degree view of the newest cath lab at...
Guideline updates and clinical research highlight the need for improved understanding of gender differences by clinicians and patients
Feature | Women's Health | May 03, 2018 | By Jeff Zagoudis
Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD).
GE's OEC Elite CFD

GE's OEC Elite CFD

Feature | Mobile C-Arms | April 18, 2018 | Jeff Zagoudis
The market for mobile C-arm techn...